GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ortin Global Ltd (BOM:539287) » Definitions » Selling and Marketing Expense

Ortin Global (BOM:539287) Selling and Marketing Expense : ₹0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Ortin Global Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Ortin Global's Selling and Marketing Expense for the three months ended in Jun. 2024 was ₹0.00 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2024 was ₹0.00 Mil.

Ortin Global Selling and Marketing Expense Historical Data

The historical data trend for Ortin Global's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ortin Global Selling and Marketing Expense Chart

Ortin Global Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.81 4.29 6.11 1.29 1.14

Ortin Global Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ortin Global Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ortin Global Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Ortin Global's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Ortin Global Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ortin Global Ltd (BOM:539287) » Definitions » Selling and Marketing Expense
Comparable Companies
BOM:524314 BOM:524752 BOM:523620 BOM:524768 BOM:532041 BOM:540359 BOM:524604 BOM:524606 BOM:524400 BOM:531210 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ORTINLAB:India
Address
Street no. 3, D. No. 1-8-B4, Ground Floor,Block-4, F3 HIG, Baghlingampally, Hyderabad, TG, IND, 500 044
Website
https://www.ortinlabsindia.com
Ortin Laboratories Ltd is an India based engaged in the manufacturing and trading of Pharmaceuticals, Drugs, and Intermediates. Its formulations include anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, antibiotics, antifungal, cephalosporins, and others. Some of its APIs Intermediates include Ciprofloxacin, Tramadol, Efavarenz, Lamivudine, Zudavudine, Nevirapine, Lopinavir, Fluconazole, Triclabendazole, Omeprazole, and others.It earns key revenue from domestic sales.

Ortin Global Headlines

No Headlines